Sign up to save your podcasts
Or
Share 4 Keys to Allo in 2024 with Poseida Therapeutics' Kristin Yarema, Ph.D.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
4 Keys to Allo in 2024 with Poseida Therapeutics' Kristin Yarema, Ph.D.
We love to hear from our listeners. Send us a message.
Kristin Yarema, Ph.D., CEO, Poseida Therapeutics sits down with Cell & Gene: The Podcast Host Erin Harris to discuss four of the biggest challenges the CGT sector faces when it comes to the development of off-the-shelf therapies. Kristin shares how 2024 might see some real progress in allogeneic therapies.
Subscribe to the podcast!
Apple | Spotify | YouTube
View all episodes
By Erin Harris
4.9
3838 ratings
We love to hear from our listeners. Send us a message.
Kristin Yarema, Ph.D., CEO, Poseida Therapeutics sits down with Cell & Gene: The Podcast Host Erin Harris to discuss four of the biggest challenges the CGT sector faces when it comes to the development of off-the-shelf therapies. Kristin shares how 2024 might see some real progress in allogeneic therapies.
Subscribe to the podcast!
Apple | Spotify | YouTube
More shows like Cell & Gene: The Podcast
View all
Nature Podcast
757 Listeners
HBR IdeaCast
177 Listeners
Planet Money
30,845 Listeners
Motley Fool Money
3,195 Listeners
Freakonomics Radio
32,291 Listeners
The Knowledge Project with Shane Parrish
2,648 Listeners
Immune
272 Listeners
The Readout Loud
318 Listeners
BioCentury This Week
29 Listeners
People I (Mostly) Admire
2,135 Listeners
Raising Health
147 Listeners
Biotech Hangout
18 Listeners
ASGCT Podcast Network
15 Listeners
NEJM AI Grand Rounds
54 Listeners
HBR On Leadership
152 Listeners